Efficacy Evaluation of the Esophagogastric Junction Exposure Obtained by the Flexible Liver Retractor in Gastroplasty
1 other identifier
interventional
100
1 country
1
Brief Summary
Evaluation of a new technique of liver retraction for the exposure of the His angle in gastric bypass Roux-en-Y surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable obesity
Started Aug 2015
Shorter than P25 for not_applicable obesity
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2016
CompletedFirst Submitted
Initial submission to the registry
October 5, 2016
CompletedFirst Posted
Study publicly available on registry
October 6, 2016
CompletedOctober 7, 2016
October 1, 2016
11 months
October 5, 2016
October 6, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Number of incisions made during laparoscopic surgery using flexible retractor when compared to conventional retractor
during surgery
Study Arms (2)
CONVENTIONAL LIVER RETRACTOR DEVICE
ACTIVE COMPARATORUSE OF CONVENTIONAL LIVER RETRACTOR FOR THE LAPAROSCOPIC ROUX-EN-Y GASTRIC BYPASS SURGERY
FLEXIBLE LIVER RETRACTOR DEVICE
EXPERIMENTALUSE OF THE FLEXIBLE LIVER RETRACTOR FOR THE LAPAROSCOPIC ROUX-EN-Y GASTRIC BYPASS SURGERY
Interventions
LIVER RETRACTION FOR THE EXPOSURE OF THE ESOPHAGOGASTRIC JUNCTION USING CONVENTIONAL RETRACTOR DEVICE
LIVER RETRACTION FOR THE EXPOSURE OF THE ESOPHAGOGASTRIC JUNCTION USING FLEXIBLE LIVER RETRACTOR DEVICE
LAPAROSCOPIC ROUX-EN-Y GASTRIC BYPASS SURGERY
Eligibility Criteria
You may qualify if:
- Between 18 - 65 years, both genders, with indication of bariatric surgery according to IFSO criteria.
- Agreed to participate and signed informed consent form.
You may not qualify if:
- Patients who did not agree to participate and / or any other condition that the investigator judged relevant for not participating in the study were excluded.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Nucleo de Pesquisa e Desenvolvimento da Universidade Federal do Ceara
Fortaleza, Ceará, 60430-275, Brazil
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Rodrigo Babadopulos, MD
Nucleo De Pesquisa E Desenvolvimento De Medicamentos Da Universidade Federal Do Ceara
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD, GASTRIC SURGEON
Study Record Dates
First Submitted
October 5, 2016
First Posted
October 6, 2016
Study Start
August 1, 2015
Primary Completion
July 1, 2016
Study Completion
August 1, 2016
Last Updated
October 7, 2016
Record last verified: 2016-10
Data Sharing
- IPD Sharing
- Will not share